000 01688 a2200505 4500
005 20250518063346.0
264 0 _c20200901
008 202009s 0 0 eng d
022 _a1476-5551
024 7 _a10.1038/s41375-019-0580-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAsnani, Mukta
245 0 0 _aRetention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19.
_h[electronic resource]
260 _bLeukemia
_c04 2020
300 _a1202-1207 p.
_bdigital
500 _aPublication Type: Letter; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
650 0 4 _aAntigens, CD19
_xchemistry
650 0 4 _aFrameshift Mutation
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aImmunotherapy, Adoptive
650 0 4 _aIntrons
_xgenetics
650 0 4 _aLeukemia
_xgenetics
650 0 4 _aPrognosis
700 1 _aHayer, Katharina E
700 1 _aNaqvi, Ammar S
700 1 _aZheng, Sisi
700 1 _aYang, Scarlett Y
700 1 _aOldridge, Derek
700 1 _aIbrahim, Fadia
700 1 _aMaragkakis, Manolis
700 1 _aGazzara, Matthew R
700 1 _aBlack, Kathryn L
700 1 _aBagashev, Asen
700 1 _aTaylor, Deanne
700 1 _aMourelatos, Zissimos
700 1 _aGrupp, Stephan A
700 1 _aBarrett, David
700 1 _aMaris, John M
700 1 _aSotillo, Elena
700 1 _aBarash, Yoseph
700 1 _aThomas-Tikhonenko, Andrei
773 0 _tLeukemia
_gvol. 34
_gno. 4
_gp. 1202-1207
856 4 0 _uhttps://doi.org/10.1038/s41375-019-0580-z
_zAvailable from publisher's website
999 _c30181077
_d30181077